DongKook Pharmaceutical Co Ltd 086450

Morningstar Rating
₩24,800.00 +1,750.00 (7.59%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

086450 is trading at a LOCK|^j<C! premium.
Price
₩23,050.00
Fair Value
LOCK|@!f.VMwD!b
Uncertainty
LOCK|>Gt&#
1-Star Price
LOCK|fFs.Xj<&!H
5-Star Price
LOCK|!mX.&<&sRk$
Economic Moat
LOCK|!Xn
Capital Allocation
—

Trading Information

Previous Close Price
₩23,050.00
Day Range
₩22,500.00–25,500.00
52-Week Range
₩16,390.00–31,250.00
Bid/Ask
₩24,550.00 / ₩24,800.00
Shares Outstanding
45.11M
Market Cap
₩1.12T
Volume/Avg
1M / 566,937

Key Statistics

Price/Earnings (Normalized)
12.90
Price/Sales
1.06
Dividend Yield (Trailing)
0.81%
Dividend Yield (Forward)
0.81%
Dividend Payment Schedule
Apr
Total Yield
0.81%

Company Profile

DongKook Pharmaceutical Co Ltd is a part of the healthcare industry based in Korea. Being a pharmaceutical company, its activities are focused on the research and development of drugs. The company produces superior medicines used favorably by consumers such as Madecassol, which is a drug for wounds and Oramedy, which is a drug for treating stomatitis. It also owns a prefilled syringe system in its second factory, through which it produces various kinds of ultramodern injection agents.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
1,269

Valuation

Metric
086450
Price/Earnings (Normalized)
12.90
Price/Book Value
1.49
Price/Sales
1.06
Price/Cash Flow
8.67
Price/Earnings
086450

Financial Strength

Metric
086450
Quick Ratio
0.00
Current Ratio
2.06
Interest Coverage
50.90
Quick Ratio
086450

Profitability

Metric
086450
Return on Assets (Normalized)
8.41%
Return on Equity (Normalized)
13.47%
Return on Invested Capital (Normalized)
10.39%
Return on Assets
086450

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|Mp#^!@chLOCK|fQZ<$72B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|<#&zF$#DLOCK|Q&^>$51B
Haleon PLC ADR
HLN
LOCK|B<nj&YLOCK|pF$40B
Zoetis Inc Class A
ZTS
LOCK|>zM^d^@yLOCK|!V$34B
Viatris Inc
VTRS
LOCK|dK?Y!tLOCK|xK$24B
Elanco Animal Health Inc
ELAN
LOCK|DcLOCK|xC$13B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|&F&CBjJLOCK|%!#$12B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|>fl%bGLOCK|js$4B
Prestige Consumer Healthcare Inc
PBH
LOCK|v#P&c!SLOCK|%Cns$2B
Perrigo Co PLC
PRGO
LOCK|<NX!@WTLOCK|%#z$2B

Sponsor Center